Dr. Elena Elimova discusses how Ziihera-based therapy may change treatment for HER2+ locally advanced or metastatic gastroesophageal adenocarcinoma.
Dr. Elena Elimova
Advertisement
Elimova is a staff medical oncologist at Princess Margaret Cancer Centre in Ontario, Canada, where she is also an associate professor in the Department of Medicine at the University of Toronto.
Articles by Dr. Elena Elimova
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CURE
1
Top 5 Gastrointestinal Cancer Stories of 2025
2
Top 5 Breast Cancer Stories of 2025: Research, Treatments and Care
3
FDA Grants Breakthrough Status to Zoldonrasib in Lung Cancer
4
Breaking Down Side Effects of Tukysa in HER2+ Breast Cancer
5